Please enable Javascript...

Research2Reports | Medical Devices | Global Irritable Bowel Syndrome (IBS) Market Analysis 2012-2017 and Forecast 2018-2023

Global Irritable Bowel Syndrome (IBS) Market Analysis 2012-2017 and Forecast 2018-2023

Medical Devices

Global Irritable Bowel Syndrome (IBS) Market Analysis 2012-2017 and Forecast 2018-2023

R2R-56378 | 19-12-2017 | 90 Pages | 99 Strategy

Snapshot
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
The global Irritable Bowel Syndrome (IBS) market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Irritable Bowel Syndrome (IBS) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
IBS-D Drug
IBS-C Drug
Other
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Valeant Pharmaceuticals
Allergan
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Women
Men
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa

Purchase this Report

Enterprise User $ 7000.00
$ 5960.00
Single User $ 3500.00
$ 2980.00

Reasons to Buy